Synonyms: compound 16c [PMID: 28918097] | WN-1703 | XOR inhibitor 16c
Compound class:
Synthetic organic
Comment: WN1703 is an inhibitor of xanthine dehydrogenase (XDH, a.k.a. XOR) [1,3]. This enzyme is the target of the hyperuricemia/gout drugs febuxostat and allopurinol.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Immunopharmacology Comments |
In a rat gout model WN1703 relieves disease symptoms by down-regulating the NLRP3/caspase-1 and TLR4/MyD88/NF-κB inflammatory signalling pathways [2]. WN1703 attenuates circulating TNF-α and IL-1β levels in vivo. |